Literature DB >> 12741471

Time course of colonic nuclear factor-kappa B expression during bacterial peptidoglycan-polysaccharide-induced colitis in rats.

Leo R Fitzpatrick1, Jian Wang, Truc Le, Noel Calingasan.   

Abstract

Nuclear factor-kappa B has been proposed to play a role in the pathogenesis of bacterial peptidoglycan-polysaccharide-induced colitis. However, its colonic expression has not been defined in detail. The primary aim of this study was to profile this expression in the rat colon. Peptigoglycan-polysaccharide was administered to the rat colon by direct intramural injections. Gross colonic injury was determined at various time points. Concomitantly, colonic nuclear factor-kappa B was measured by an electrophoretic mobility shift assay and by immunohistochemistry. Gross colonic injury and colonic nuclear factor-kappa B expression showed similar time courses following peptigoglycan-polysaccharide administration. Peak colonic injury and nuclear factor-kappa B expression were found on day 21. Nuclear factor-kappa B was mainly expressed in submucosal inflammatory cells. In conclusion, the administration of bacterial peptidoglycan-polysaccharide to the rat colon caused a chronic colitis, which was characterized by up-regulated colonic nuclear factor-kappa B.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12741471     DOI: 10.1023/a:1022853213009

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats.

Authors:  L R Fitzpatrick; J Wang; T Le
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

2.  Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts.

Authors:  E A van Tol; L Holt; F L Li; F M Kong; R Rippe; M Yamauchi; J Pucilowska; P K Lund; R B Sartor
Journal:  Am J Physiol       Date:  1999-07

3.  Effects of cyclosporine or FK506 in chronic colitis.

Authors:  S Aiko; E M Conner; J A Fuseler; M B Grisham
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

4.  Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats.

Authors:  Leo R Fitzpatrick; Jian Wang; Truc Le
Journal:  Inflamm Bowel Dis       Date:  2002-05       Impact factor: 5.325

5.  Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease.

Authors:  K Thiele; A Bierhaus; F Autschbach; M Hofmann; W Stremmel; H Thiele; R Ziegler; P P Nawroth
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

6.  Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats.

Authors:  T Yamada; R B Sartor; S Marshall; R D Specian; M B Grisham
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

7.  Bacterial Cell Wall Polymer-Induced Granulomatous Inflammation

Authors: 
Journal:  Methods       Date:  1996-04       Impact factor: 3.608

Review 8.  Nuclear factor kappa B: important transcription factor and therapeutic target.

Authors:  J I Lee; G J Burckart
Journal:  J Clin Pharmacol       Date:  1998-11       Impact factor: 3.126

9.  Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.

Authors:  R D McCall; S Haskill; E M Zimmermann; P K Lund; R C Thompson; R B Sartor
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

10.  Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.

Authors:  G Rogler; K Brand; D Vogl; S Page; R Hofmeister; T Andus; R Knuechel; P A Baeuerle; J Schölmerich; V Gross
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.